Viewing Study NCT02929420


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-03 @ 9:15 PM
Study NCT ID: NCT02929420
Status: UNKNOWN
Last Update Posted: 2016-10-11
First Post: 2016-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Organization:

Study Overview

Official Title: A Multicenter, Randomized, Open, Parallel Controlled Clinical Study on the Efficacy and Safety of the Treatment of Cyclomastopathy With Xiaoru Sanjie Capsule
Status: UNKNOWN
Status Verified Date: 2016-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Xiaoru Sanjie capsule in the treatment of cyclomastopathy.
Detailed Description: This is a multicenter, randomized, open and parallel controlled clinical study.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: